Kentaro Suina

Gold-nanofève surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival

Megumi Shiota, Masayuki Naya, Takehiro Yamamoto et al. · Nature Communications · 2018 · 98 citations · Full text

Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma

Shogo Okazaki, Kiyoko Umene, Juntaro Yamasaki et al. · Cancer Science · 2019 · 84 citations · Full text

Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells

Shogo Okazaki, Subaru Shintani, Yuki Hirata et al. · Oncotarget · 2018 · 80 citations · Full text

Drug Library, Synthetic Lethality, Redox Biology +18

Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)

Kohei Shitara, Toshihiko Doi, Osamu Nagano et al. · Gastric Cancer · 2017 · 57 citations · Full text

Gastrointestinal Oncology, Medicine, Cancer Management +7

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer

Kohei Otsubo, Kaname Nosaki, Chiyo K. Imamura et al. · Cancer Science · 2017 · 56 citations · Full text